Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease

Sponsor
Fu Jen Catholic University
Study ID
NCT07474220
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

This study aims to investigate the expression level of SLC25A48, a mitochondrial choline transporter, in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease, and to analyze its correlation with inflammatory markers and choline metabolic byproducts.

Key Dates

First listed
Mar 16, 2026
Start date
Jun 29, 2026
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
180 participants (estimated)

Arms

  • Arm: Case group
    Pre-COPD or COPD stages I-IV as per the 2023 GOLD guidelines
  • Arm: Control group
    healthy controls

Primary Outcome Measure

expression of SLC25A48 [ Time Frame: one day ]

Central Contacts

Find similar trials

Nationwide
COPD trialsPulmonology trialsLung disease trials

Related Studies